We are live on ! Find out more

1,970 hedge funds and large institutions have $146B invested in Pfizer in 2015 Q4 according to their latest regulatory filings, with 195 funds opening new positions, 801 increasing their positions, 756 reducing their positions, and 80 closing their positions.

New
Increased
Maintained
Reduced
Closed

144% more first-time investments, than exits

New positions opened: 195 | Existing positions closed: 80

5% more funds holding

Funds holding: 1,8801,970 (+90)

1.41% more ownership

Funds ownership: 75.71%77.11% (+1.4%)

6% more repeat investments, than reductions

Existing positions increased: 801 | Existing positions reduced: 756

4% more capital invested

Capital invested by funds: $140B → $146B (+$6.18B)

5% less funds holding in top 10

Funds holding in top 10: 267253 (-14)

39% less call options, than puts

Call options by funds: $1.79B | Put options by funds: $2.95B

Holders
1,970
Holders Change
+90
Holders Change %
+4.79%
% of All Funds
51.67%
Holding in Top 10
253
Holding in Top 10 Change
-14
Holding in Top 10 Change %
-5.24%
% of All Funds
6.64%
New
195
Increased
801
Reduced
756
Closed
80
Calls
$1.79B
Puts
$2.95B
Net Calls
-$1.16B
Net Calls Change
-$1.83B
Name Holding Trade Value Shares
Change
Change in
Stake
SFA
1501
Sequoia Financial Advisors
Ohio
$713K +$68.8K +2,186 +10%
MSS
1502
Mitchell Sinkler & Starr
Pennsylvania
$710K -$119K -3,795 -14%
SHCM
1503
Stokes & Hubbell Capital Management
Louisiana
$709K -$8.27K -263 -1%
CFA
1504
CT Financial Advisors
Pennsylvania
$707K -$23K -731 -3%
NPT
1505
Nixon Peabody Trust
Massachusetts
$704K +$723K +22,995 New
CC
1506
Capital Counsel
New York
$698K +$300K +9,533 +72%
MIC
1507
MU Investments Company
Japan
$696K -$616K -19,583 -46%
RPA
1508
Rock Point Advisors
Vermont
$696K -$4.12K -131 -0.6%
AWM
1509
Arbor Wealth Management
Florida
$694K +$803K +25,523 New
BCM
1510
BTR Capital Management
California
$692K +$215K +6,832 +43%
PTB
1511
Pioneer Trust Bank
Oregon
$691K
CCS
1512
Crosspoint Capital Strategies
California
$689K -$30.7K -976 -4%
VNA
1513
Valley National Advisers
Pennsylvania
$687K +$196K +6,239 +39%
HTHT
1514
Hemenway Trust Hemenway Trust
New Hampshire
$683K -$90.4K -2,875 -11%
SCP
1515
Sandhill Capital Partners
New York
$683K +$5.63K +179 +0.8%
CFA
1516
Camarda Financial Advisors
Florida
$682K +$11.8K +374 +2%
BMC
1517
Benin Management Corp
Connecticut
$679K -$23.8K -758 -3%
KLWA
1518
Kelly Lawrence W & Associates
California
$677K -$34.9K -1,108 -5%
FDCC
1519
Foster Dykema Cabot & Co
Massachusetts
$677K -$15.2K -483 -2%
MIM
1520
Montgomery Investment Management
Maryland
$677K
SAM
1521
Summit Asset Management
Tennessee
$676K -$116K -3,686 -14%
CMANY
1522
Capital Management Associates (New York)
New York
$675K -$43.1K -1,370 -6%
SFPIA
1523
Stevens First Principles Investment Advisors
California
$674K
BCM
1524
Brookstone Capital Management
Illinois
$674K +$4.59K +146 +0.7%
KCPG
1525
Kavar Capital Partners Group
Kansas
$673K

PFE Hedge Fund Activity: Q4 2015 in Review

1,970 of the 3,813 institutional investors tracked by Wall St. Rank reported a position in Pfizer (PFE) for Q4 2015, worth a combined $146B — up 4.4% from $140B a quarter earlier.

Buyers outnumbered sellers: 195 funds opened new PFE positions and 80 closed out — a net gain of 115 holders — while 801 added to existing stakes and 756 trimmed.

The largest buyer was Deutsche Bank, adding an estimated $604M. The largest seller was Capital World Investors, cutting an estimated $1.47B.

  • 1,970 institutional investors held Pfizer (PFE) as of Q4 2015, up from 1,880 in Q3 2015.
  • Funds reported $146B of Pfizer stock for Q4 2015, up 4.4% quarter-over-quarter.
  • 195 funds opened new Pfizer positions in Q4 2015 and 80 closed out, a net change of +115 holders.
  • The largest Pfizer buyer in Q4 2015 was Deutsche Bank, an estimated $604M added.
  • The largest Pfizer seller in Q4 2015 was Capital World Investors, an estimated $1.47B sold.

Based on aggregated 13F filings for Q4 2015.